Cargando…
Does lesion type or severity predict outcome of therapy for horses with equine glandular gastric disease? – A retrospective study
BACKGROUND: Equine glandular gastric disease (EGGD) is a common condition of the horse. Misoprostol is reported to be superior to oral omeprazole and sucralfate for treatment. Long‐acting intramuscular injectable omeprazole (LAIOMEP) is a novel treatment shown to be effective in a small population....
Autores principales: | Pratt, S. L., Bowen, M., Hallowell, G. H., Shipman, E., Bailey, J., Redpath, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857143/ https://www.ncbi.nlm.nih.gov/pubmed/36495212 http://dx.doi.org/10.1002/vms3.1034 |
Ejemplares similares
-
Assessment of agreement using the equine glandular gastric disease grading system in 84 cases
por: Pratt, Stefanie, et al.
Publicado: (2022) -
Gastric microbiome in horses with and without equine glandular gastric disease
por: Paul, Linda J., et al.
Publicado: (2021) -
Evaluation of the treatment of equine glandular gastric disease with either long‐acting‐injectable or oral omeprazole
por: Gough, Sarah, et al.
Publicado: (2022) -
An objective study into the effects of an incline on naturally occurring lameness in horses
por: Bailey, James, et al.
Publicado: (2022) -
Effect of diet composition on glandular gastric disease in horses
por: Julliand, Samy, et al.
Publicado: (2023)